The Traderszone Network

Published in TZ Latest News 5 July, 2017 by The TZ Newswire Staff

Array BioPharma’s New FDA Submissions Enough to Excite Investors?

Array BioPharma has announced the submission to the FDA of two New Drug Applications to support the use of the combination of binimetinib and encorafenib for the treatment of patients with melanoma.